Approaches to kidney replacement therapies-opportunities and challenges
- PMID: 35982852
- PMCID: PMC9380013
- DOI: 10.3389/fcell.2022.953408
Approaches to kidney replacement therapies-opportunities and challenges
Abstract
One out of seven people develop chronic kidney disease (CKD). When kidney function continues to decline, CKD patients may develop end-stage renal disease (ESRD, or kidney failure). More than 2 out of 1,000 adults develop ESRD and these patients must live on dialysis or get a kidney transplant to survive. Each year, more than $51 billion is spent to treat patients with ESRD in the United States. In addition, ESRD greatly reduces longevity and quality of life for patients. Compared to dialysis, kidney transplant offers the best chance of survival, but few donor organs are available. Thus, there is an urgent need for innovative solutions that address the shortage of kidneys available for transplantation. Here we summarize the status of current approaches that are being developed to solve the shortage of donor kidneys. These include the bioartificial kidney approach which aims to make a portable dialysis device, the recellularization approach which utilizes native kidney scaffold to make an engineered kidney, the stem cell-based approach which aims to generate a kidney de novo by recapitulating normal kidney organogenesis, the xenotransplantation approach which has the goal to make immunocompatible pig kidneys for transplantation, and the interspecies chimera approach which has potential to generate a human kidney in a host animal. We also discuss the interconnections among the different approaches, and the remaining challenges of translating these approaches into novel therapies.
Keywords: bioartificial kidney; bioengineering (general); decellularizalion; genome editing; interspecies chimera; kidney organoid; pluripotent stem cells; xenotransplant.
Copyright © 2022 Huang, Zeng, Zhang, Schreiber and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Kidney Bioengineering for Transplantation.Transplantation. 2023 Sep 1;107(9):1883-1894. doi: 10.1097/TP.0000000000004526. Epub 2023 Aug 21. Transplantation. 2023. PMID: 36717963
-
Treatment for end-stage renal disease: an organogenesis/tissue engineering odyssey.Transpl Immunol. 2004 Apr;12(3-4):211-8. doi: 10.1016/j.trim.2003.12.001. Transpl Immunol. 2004. PMID: 15157915 Review.
-
Renal bioengineering with scaffolds generated from rat and pig kidneys.Nephron Exp Nephrol. 2014;126(2):113. doi: 10.1159/000360683. Epub 2014 May 19. Nephron Exp Nephrol. 2014. PMID: 24854652 Review.
-
Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.Xenotransplantation. 2019 Mar;26(2):e12471. doi: 10.1111/xen.12471. Epub 2018 Nov 20. Xenotransplantation. 2019. PMID: 30456901 Free PMC article. Review.
-
Bioengineering strategies for nephrologists: kidney was not built in a day.Expert Opin Biol Ther. 2020 May;20(5):467-480. doi: 10.1080/14712598.2020.1709439. Epub 2020 Jan 23. Expert Opin Biol Ther. 2020. PMID: 31971029 Review.
Cited by
-
Transitioning of renal transplant pathology from allograft to xenograft and tissue engineering pathology: Are we prepared?World J Transplant. 2023 Mar 18;13(3):86-95. doi: 10.5500/wjt.v13.i3.86. World J Transplant. 2023. PMID: 36968134 Free PMC article. Review.
-
Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem in CKD and hemodialysis individuals.Front Pharmacol. 2023 Mar 7;14:1126714. doi: 10.3389/fphar.2023.1126714. eCollection 2023. Front Pharmacol. 2023. PMID: 36959849 Free PMC article.
-
Prevalence and risk factors of falls in people on hemodialysis: a systematic review and meta-analysis.Ren Fail. 2025 Dec;47(1):2485375. doi: 10.1080/0886022X.2025.2485375. Epub 2025 Apr 9. Ren Fail. 2025. PMID: 40204427 Free PMC article.
-
Preclinical approaches in regenerative medicine for treating end-stage renal disease: a scoping review.Front Endocrinol (Lausanne). 2025 Jul 18;16:1549744. doi: 10.3389/fendo.2025.1549744. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40756517 Free PMC article. Review.
References
-
- Abolbashari M., Agcaoili S. M., Lee M. K., Ko I. K., Aboushwareb T., Jackson J. D., et al. (2016). Repopulation of porcine kidney scaffold using porcine primary renal cells. Acta Biomater. 29, 52–61. 10.1016/j.actbio.2015.11.026 PubMed Abstract | 10.1016/j.actbio.2015.11.026 | Google Scholar - DOI - DOI - PubMed
-
- Brown A. C., Muthukrishnan S. D., Oxburgh L. (2015). A synthetic niche for nephron progenitor cells. Dev. Cell 34, 229–241. 10.1016/j.devcel.2015.06.021 PubMed Abstract | 10.1016/j.devcel.2015.06.021 | Google Scholar - DOI - DOI - PMC - PubMed
-
- Buffington D. A., Pino C. J., Chen L., Westover A. J., Hageman G., Humes H. D. (2012). Bioartificial renal epithelial cell system (BRECS): A compact, cryopreservable extracorporeal renal replacement device. Cell Med. 4, 33–43. 10.3727/215517912X653328 PubMed Abstract | 10.3727/215517912X653328 | Google Scholar - DOI - DOI - PMC - PubMed
-
- Cacalano G., FarInas I., Wang L. C., Hagler K., Forgie A., MooreM., et al. (1998). GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21, 53–62. 10.1016/s0896-6273(00)80514-0 PubMed Abstract | 10.1016/s0896-6273(00)80514-0 | Google Scholar - DOI - DOI - PMC - PubMed
-
- Caralt M., Uzarski J. S., Iacob S., Obergfell K. P., BergN., Bijonowski B. M., et al. (2015). Optimization and critical evaluation of decellularization strategies to develop renal extracellular matrix scaffolds as biological templates for organ engineering and transplantation. Am. J. Transpl. 15, 64–75. 10.1111/ajt.12999 10.1111/ajt.12999 | Google Scholar - DOI - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources